ClinicalTrialsFinder

Refractory Lupus Nephritis Clinical Trials in Beijing, China,Beijing

1 recruitingBeijing, China,Beijing, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension
Beijing GoBroad Hospital45 enrolled1 locationNCT06947460